Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takero Shindo

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Stem Cell Investigation|November 22, 2016
Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphomaShigeo Fuji, Takero Shindo
International Journal of Hematology|May 27, 2026
Real-world treatments and outcomes of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a Japanese claims analysisTakero Shindo, Mami Shindo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Immune defects in multiple myeloma]Takero Shindo, Shinya Kimura
Leukemia Research|November 26, 2019
Role of cancer immunology in chronic myelogenous leukemiaHiroshi Ureshino, Takero Shindo, Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2017
Chronic myeloid leukemia and NK cell immunityHiroshi Ureshino, Takero Shindo, Hidenori Tanaka, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 26, 2021
T-cell chimerism prior to graft-versus-host diseaseMisa Noguchi, Takero Shindo, Yosuke Yamada, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2002
[Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy]Takero Shindo, Yoshikazu Yumoto, Michiaki Yoshida, et al.
Blood Advances|February 21, 2020
Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantationHidekazu Itamura, Takero Shindo, Satoshi Yoshioka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipientsTakero Shindo, Takayuki Ishikawa, Akiko Fukunaga, et al.
Cureus|December 30, 2024
Acalabrutinib and Obinutuzumab for Chronic Lymphocytic Leukemia Complicated With Peripheral NeuropathyTaro Edahiro, Hiroshi Ureshino, Masahiro Nakamori, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Stem Cell Investigation|November 22, 2016
Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphomaShigeo Fuji, Takero Shindo
International Journal of Hematology|May 27, 2026
Real-world treatments and outcomes of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a Japanese claims analysisTakero Shindo, Mami Shindo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Immune defects in multiple myeloma]Takero Shindo, Shinya Kimura
Leukemia Research|November 26, 2019
Role of cancer immunology in chronic myelogenous leukemiaHiroshi Ureshino, Takero Shindo, Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2017
Chronic myeloid leukemia and NK cell immunityHiroshi Ureshino, Takero Shindo, Hidenori Tanaka, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 26, 2021
T-cell chimerism prior to graft-versus-host diseaseMisa Noguchi, Takero Shindo, Yosuke Yamada, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2002
[Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy]Takero Shindo, Yoshikazu Yumoto, Michiaki Yoshida, et al.
Blood Advances|February 21, 2020
Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantationHidekazu Itamura, Takero Shindo, Satoshi Yoshioka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipientsTakero Shindo, Takayuki Ishikawa, Akiko Fukunaga, et al.
Cureus|December 30, 2024
Acalabrutinib and Obinutuzumab for Chronic Lymphocytic Leukemia Complicated With Peripheral NeuropathyTaro Edahiro, Hiroshi Ureshino, Masahiro Nakamori, et al.
Pageof 7